Albert Dahan Selected Research

norketamine

1/2022	Ketamine Psychedelic and Antinociceptive Effects Are Connected.
8/2012	Estimation of the contribution of norketamine to ketamine-induced acute pain relief and neurocognitive impairment in healthy volunteers.
7/2011	Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
10/2009	S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Dahan Research Topics

Disease

77	Pain (Aches) 01/2022 - 01/2004
55	Respiratory Insufficiency (Respiratory Failure) 11/2022 - 02/2003
28	Chronic Pain 12/2019 - 10/2009
20	Postoperative Pain 12/2020 - 06/2006
19	Neuralgia (Stump Neuralgia) 01/2021 - 07/2008
17	Hyperalgesia 01/2021 - 06/2009
9	Hypoxia (Hypoxemia) 11/2022 - 11/2002
8	Acute Pain 01/2018 - 11/2004
8	Complex Regional Pain Syndromes 04/2015 - 10/2009
7	Opiate Overdose 11/2022 - 03/2007
7	Apnea 01/2022 - 06/2010
6	Fibromyalgia (Fibrositis) 10/2019 - 10/2011
6	Cancer Pain 01/2017 - 01/2006
5	Sarcoidosis (Schaumann Disease) 01/2018 - 01/2012
5	Nausea 01/2018 - 06/2006
5	Vomiting 02/2014 - 06/2006
4	Neoplasms (Cancer) 03/2013 - 07/2008
3	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 03/2007
3	Hyperoxia 12/2021 - 04/2004
3	Chronic Pancreatitis 11/2019 - 12/2012
3	Sleep Apnea Syndromes (Sleep Apnea) 10/2019 - 04/2004
3	Postoperative Nausea and Vomiting (PONV) 04/2011 - 05/2008
2	Heart Arrest (Cardiac Arrest) 11/2022 - 01/2016
2	Renal Insufficiency (Renal Failure) 01/2022 - 11/2015
2	Body Weight (Weight, Body) 05/2018 - 02/2015
2	Obesity 12/2017 - 07/2014
2	Pneumoperitoneum 11/2017 - 08/2015
2	Miosis 01/2017 - 05/2015
2	Peripheral Nerve Injuries 07/2016 - 11/2011
2	Type 2 Diabetes Mellitus (MODY) 07/2016 - 03/2015
2	Psychotic Disorders (Schizoaffective Disorder) 12/2015 - 04/2015
2	Hallucinations (Hallucination) 12/2015 - 02/2014
2	Inflammation (Inflammations) 02/2014 - 07/2010
1	Myasthenia Gravis 01/2022
1	Hemorrhage 01/2022

Drug/Important Bio-Agent (IBA)

68	Opioid Analgesics (Opioids)IBA 11/2022 - 03/2005
36	Analgesics (Analgesic Drugs)IBA 01/2020 - 02/2003
30	Ketamine FDA LinkGeneric 01/2022 - 10/2009
27	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 10/2003
20	Pharmaceutical PreparationsIBA 01/2022 - 05/2008
19	Fentanyl (Sublimaze)FDA LinkGeneric 11/2022 - 01/2006
15	Naloxone (Narcan)FDA LinkGeneric 11/2022 - 02/2003
15	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2019 - 06/2009
13	Buprenorphine (Subutex)FDA LinkGeneric 01/2022 - 01/2006
12	EsketamineIBA 01/2017 - 10/2009
10	Remifentanil (Ultiva)FDA Link 01/2022 - 06/2010
10	Opioid Receptors (Opioid Receptor)IBA 01/2022 - 02/2003
10	morphine-6-glucuronideIBA 12/2017 - 10/2003
7	Narcotic Antagonists (Opioid Antagonists)IBA 11/2022 - 07/2006
6	mu Opioid Receptors (mu Opioid Receptor)IBA 11/2022 - 03/2005
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
6	Carbon DioxideIBA 10/2020 - 04/2004
6	cibinetideIBA 01/2018 - 11/2011
5	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2022 - 11/2011
4	Naltrexone (ReVia)FDA LinkGeneric 01/2022 - 06/2009
4	Sufentanil (Sufenta)FDA LinkGeneric 01/2022 - 11/2007
4	norketamineIBA 01/2022 - 10/2009
4	Alfentanil (Alfenta)FDA LinkGeneric 01/2018 - 07/2005
4	Erythropoietin FDA Link 03/2015 - 11/2011
4	Peptides (Polypeptides)IBA 03/2015 - 11/2011
3	Propofol (Diprivan)FDA LinkGeneric 10/2021 - 04/2002
3	Tapentadol FDA Link 11/2020 - 01/2015
3	Pregabalin (Lyrica)FDA Link 11/2019 - 12/2012
3	N-Methylaspartate (NMDA)IBA 07/2011 - 01/2010
3	Acetazolamide (Diamox)FDA LinkGeneric 01/2010 - 04/2004
3	Dizocilpine Maleate (Dizocilpine)IBA 01/2010 - 06/2009
2	Hypnotics and Sedatives (Sedatives)IBA 01/2022 - 01/2016
2	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 01/2022 - 01/2022
2	SugammadexIBA 01/2022 - 01/2019
2	Neostigmine (Neostigmine Bromide)IBA 01/2022 - 01/2019
2	Retinaldehyde (Retinal)IBA 12/2021 - 01/2021
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019 - 01/2018
2	TabletsIBA 01/2018 - 01/2018
2	morphine-3-glucuronideIBA 12/2017 - 12/2012
2	Oxycodone (Oxycontin)FDA LinkGeneric 03/2017 - 07/2008
2	insulin receptor-related receptor (IRR)IBA 07/2016 - 01/2013
2	Capsaicin (Zostrix)FDA Link 04/2015 - 01/2012
2	salicylhydroxamic acid (SHAM)IBA 08/2014 - 07/2007
2	EnzymesIBA 07/2014 - 12/2012
2	Methadone (Dolophine)FDA LinkGeneric 03/2013 - 07/2008
2	AntioxidantsIBA 05/2006 - 11/2002
2	Isoflurane FDA LinkGeneric 07/2005 - 04/2005
1	carfentanil (carfentanyl)IBA 11/2022
1	Levodopa (L Dopa)FDA LinkGeneric 01/2022
1	LigandsIBA 01/2022

Therapy/Procedure

38	Analgesia 11/2020 - 11/2004
13	Therapeutics 01/2022 - 01/2007
5	Epidural Analgesia 01/2018 - 11/2007
4	Nephrectomy 01/2020 - 08/2015
3	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2018 - 07/2012
3	Aftercare (After-Treatment) 01/2015 - 07/2011
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2015
2	Length of Stay 10/2020 - 07/2019
2	Spinal Anesthesia 01/2020 - 08/2014
2	Anesthesia 01/2020 - 01/2019
2	Pain Management 01/2018 - 09/2013
2	Bariatric Surgery 07/2017 - 01/2016
2	Intravenous Infusions 10/2011 - 10/2009
1	Induced Heart Arrest (Cardioplegia) 11/2022
1	Injections 01/2022